Kolexia
Bernit Emmanuelle
Médecine interne
Hôpital aux Abymes
Les Abymes, France
151 Activités
2 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Maladie associée aux immunoglobulines G4 Syndrome des anticorps antiphospholipides Sarcoïdose Myosite Anémie Hépatite COVID-19 Sténose pathologique

Industries

Novartis
8 collaboration(s)
Dernière en 2021
GSK
2 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
Medicina (Kaunas, Lithuania)   18 décembre 2023
Allogreffe de cellules souches hématopoïétiques chez les patients adolescents et adultes atteints de drépanocytose
87e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2023
Double-Blind Randomized Study to Evaluate the Effect of Hydroxycarbamide on Albuminuria in Adults with Sickle Cell Disease: Sikamic (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optimizing Albuminuria Assessment in Patients with Sickle Cell Disease: Insights from the Sikamic Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.
Haematologica   19 octobre 2023
and Genetic Polymorphisms Associated with Alloimmunisation in Sickle Cell Disease.
International journal of molecular sciences   02 septembre 2023
SIKAMIC: Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Essai Clinique (Addmedica)   14 juin 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023
Outcomes of Pregnancy in Sickle Cell Disease Patients: Results from the Prospective ESCORT-HU Cohort Study.
Biomedicines   17 février 2023